Attenade d-methylphenidate: Phase III

CELG presented previously reported data from two trials involving more than 200 children in which Attenade gave a significant improvement on a behavioral scale compared to placebo (p=0.0003), and had a significantly longer duration of action than Ritalin (p=0.015) as measured by a behavioral scale (see BioCentury, Sept. 13). Data were presented at the American Academy of Child and Adolescent Psychiatry meeting in Chicago. ...